Manchin Raises Doubts on Safety Net Bill, Complicating Path to Quick Votenews2021-11-01T23:14:05+00:00November 1st, 2021|The New York Times|
Why Aren’t More People Comparison Shopping for Health Plans?news2021-10-30T09:00:21+00:00October 30th, 2021|The New York Times|
This May Be Democrats’ Best Chance to Lower Drug Pricesnews2021-10-27T15:01:32+00:00October 27th, 2021|The New York Times|
Biden Administration Goes Bigger on Cutting Drug Pricesnews2021-09-09T18:08:05+00:00September 9th, 2021|The New York Times|
Headache Research Advances Though Cures Are Elusivenews2021-07-23T09:00:14+00:00July 23rd, 2021|The New York Times|
Biogen’s Aduhelm Sales Total $2 Million in Second Quarternews2021-07-22T21:10:02+00:00July 22nd, 2021|The New York Times|
A New Alzheimer’s Drug Offers More Questions Than Answersnews2021-07-09T19:14:45+00:00July 9th, 2021|The New York Times|
In Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drugnews2021-07-09T19:12:53+00:00July 9th, 2021|The New York Times|
